129 related articles for article (PubMed ID: 23145891)
1. MTHFR C677T polymorphism modifies the effect of HRT on metabolic parameters in postmenopausal women.
Lambrinoudaki I; Papadimitriou D; Kaparos G; Rizos D; Panoulis C; Deligeoroglou E; Alexandrou A; Auguolea A; Apostolakis M; Creatsa M; Kouskouni E
Climacteric; 2013 Oct; 16(5):568-75. PubMed ID: 23145891
[TBL] [Abstract][Full Text] [Related]
2. Low dietary riboflavin but not folate predicts increased fracture risk in postmenopausal women homozygous for the MTHFR 677 T allele.
Yazdanpanah N; Uitterlinden AG; Zillikens MC; Jhamai M; Rivadeneira F; Hofman A; de Jonge R; Lindemans J; Pols HA; van Meurs JB
J Bone Miner Res; 2008 Jan; 23(1):86-94. PubMed ID: 17725378
[TBL] [Abstract][Full Text] [Related]
3. Contribution of thermolabile methylenetetrahydrofolate reductase variant to total plasma homocysteine levels in healthy men and women. Inter99 (2).
Husemoen LL; Thomsen TF; Fenger M; Jørgensen HL; Jørgensen T
Genet Epidemiol; 2003 May; 24(4):322-30. PubMed ID: 12687650
[TBL] [Abstract][Full Text] [Related]
4. Methylenetetrahydrofolate reductase C677T polymorphism in Iraqi patients with ischemic stroke.
Al-Allawi NA; Avo AS; Jubrael JM
Neurol India; 2009; 57(5):631-5. PubMed ID: 19934565
[TBL] [Abstract][Full Text] [Related]
5. MTHFR C677T polymorphism affects normotensive diastolic blood pressure independently of blood lipids.
Heifetz EM; Birk RZ
Am J Hypertens; 2015 Mar; 28(3):387-92. PubMed ID: 25165067
[TBL] [Abstract][Full Text] [Related]
6. A common methylenetetrahydrofolate reductase (C677T) polymorphism is associated with low bone mineral density and increased fracture incidence after menopause: longitudinal data from the Danish osteoporosis prevention study.
Abrahamsen B; Madsen JS; Tofteng CL; Stilgren L; Bladbjerg EM; Kristensen SR; Brixen K; Mosekilde L
J Bone Miner Res; 2003 Apr; 18(4):723-9. PubMed ID: 12674333
[TBL] [Abstract][Full Text] [Related]
7. Gene--nutrition interactions in coronary artery disease: correlation between the MTHFR C677T polymorphism and folate and homocysteine status in a Korean population.
Huh HJ; Chi HS; Shim EH; Jang S; Park CJ
Thromb Res; 2006; 117(5):501-6. PubMed ID: 15935452
[TBL] [Abstract][Full Text] [Related]
8. ESR1 and APOE gene polymorphisms, serum lipids, and hormonal replacement therapy.
Almeida S; Fiegenbaum M; de Andrade FM; Osório-Wender MC; Hutz MH
Maturitas; 2006 May; 54(2):119-26. PubMed ID: 16242874
[TBL] [Abstract][Full Text] [Related]
9. Interaction between Mediterranean diet and methylenetetrahydrofolate reductase C677T mutation on oxidized low density lipoprotein concentrations: the ATTICA study.
Pitsavos C; Panagiotakos D; Trichopoulou A; Chrysohoou C; Dedoussis G; Chloptsios Y; Choumerianou D; Stefanadis C
Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):91-9. PubMed ID: 16487909
[TBL] [Abstract][Full Text] [Related]
10. Effect of hormone replacement therapy on plasma lipoproteins and apolipoproteins, endothelial function and myocardial perfusion in postmenopausal women with estrogen receptor-alpha IVS1-397 C/C genotype and established coronary artery disease.
Emre A; Sahin S; Erzik C; Nurkalem Z; Oz D; Cirakoglu B; Yesilcimen K; Ersek B
Cardiology; 2006; 106(1):44-50. PubMed ID: 16612068
[TBL] [Abstract][Full Text] [Related]
11. MTHFR C677T and eNOS G894T variants in preeclamptic women: Contribution to lipid peroxidation and oxidative stress.
Rahimi Z; Malek-Khosravi S; Rahimi Z; Jalilvand F; Parsian A
Clin Biochem; 2013 Jan; 46(1-2):143-7. PubMed ID: 23103710
[TBL] [Abstract][Full Text] [Related]
12. Association of methylenetetrahydrofolate reductase C677T polymorphism and serum lipid levels in the Guangxi Bai Ku Yao and Han populations.
Zhang L; Yin RX; Liu WY; Miao L; Wu DF; Aung LH; Hu XJ; Cao XL; Wu JZ; Pan SL
Lipids Health Dis; 2010 Oct; 9():123. PubMed ID: 20977771
[TBL] [Abstract][Full Text] [Related]
13. Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism is associated with osteoporotic vertebral fractures, but is a weak predictor of BMD.
Villadsen MM; Bünger MH; Carstens M; Stenkjaer L; Langdahl BL
Osteoporos Int; 2005 Apr; 16(4):411-6. PubMed ID: 15300362
[TBL] [Abstract][Full Text] [Related]
14. Effects of transdermal and oral estrogen replacement on lipids and glucose metabolism in postmenopausal women with type 2 diabetes mellitus.
Araújo DA; Farias ML; Andrade AT
Climacteric; 2002 Sep; 5(3):286-92. PubMed ID: 12419087
[TBL] [Abstract][Full Text] [Related]
15. Effects of hormone replacement therapy on glucose and lipid profiles and on cardiovascular risk parameters in postmenopausal women.
Bingol B; Gunenc Z; Yilmaz M; Biri A; Tiras B; Güner H
Arch Gynecol Obstet; 2010 May; 281(5):857-64. PubMed ID: 19593578
[TBL] [Abstract][Full Text] [Related]
16. Hyperhomocysteinaemia, methylenetetrahydrofolate reductase polymorphism and risk of coronary artery disease.
Kerkeni M; Addad F; Chauffert M; Myara A; Gerhardt M; Chevenne D; Trivin F; Farhat MB; Miled A; Maaroufi K
Ann Clin Biochem; 2006 May; 43(Pt 3):200-6. PubMed ID: 16704755
[TBL] [Abstract][Full Text] [Related]
17. Supplementation with Watermelon Extract Reduces Total Cholesterol and LDL Cholesterol in Adults with Dyslipidemia under the Influence of the MTHFR C677T Polymorphism.
Massa NM; Silva AS; de Oliveira CV; Costa MJ; Persuhn DC; Barbosa CV; Gonçalves MD
J Am Coll Nutr; 2016 Aug; 35(6):514-520. PubMed ID: 26934084
[TBL] [Abstract][Full Text] [Related]
18. Elderly women: homocysteine reduction by short-term folic acid supplementation resulting in increased glucose concentrations and affecting lipid metabolism (C677T MTHFR polymorphism).
Chmurzynska A; Malinowska AM; Twardowska-Rajewska J; Gawecki J
Nutrition; 2013 Jun; 29(6):841-4. PubMed ID: 23298970
[TBL] [Abstract][Full Text] [Related]
19. Hepatic lipase C-480T genotype-dependent benefit from long-term hormone replacement therapy for atherosclerosis progression in postmenopausal women.
Fan YM; Dastidar P; Jokela H; Punnonen R; Lehtimäki T
J Clin Endocrinol Metab; 2005 Jun; 90(6):3786-92. PubMed ID: 15755868
[TBL] [Abstract][Full Text] [Related]
20. The C677T methylenetetrahydrofolate reductase polymorphism influences the homocysteine-lowering effect of hormone replacement therapy.
Brown CA; McKinney KQ; Young KB; Norton HJ
Mol Genet Metab; 1999 May; 67(1):43-8. PubMed ID: 10329022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
